Amgen | Créances Commerciales



Trade Debtors Changement Date
AbbVie USD 12.48B 1.56B 2025-03
Agios Pharmaceuticals USD 4.99M 1.64M 2025-06
ALKERMES USD 356.33M 34.58M 2025-06
Amgen USD 8.7B 569M 2025-06
Biogen USD 2.08B 87.5M 2025-06
BioMarin Pharmaceutical USD 855.85M 116.68M 2025-06
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Eli Lilly USD 17.21B 3.2B 2025-06
Exelixis USD 292.35M 10.72M 2025-07
Genmab DKK 998M 199M 2025-06
Gilead Sciences USD 4.78B 393M 2025-06
GlaxoSmithKline GBP 7.7B 196M 2025-06
Glaxosmithkline GBP 7.32B 542M 2024-12
Incyte USD 842.89M 19.76M 2025-06
Ionis Pharmaceuticals USD 52.58M 12.87M 2025-06
J&J USD 16.02B 1.18B 2025-03
Merck USD 12.72B 1.14B 2025-06
Moderna USD 457M 151M 2025-06
Neurocrine Biosciences USD 595.7M 79.7M 2025-06
Novartis USD 9.18B 451M 2025-06
Novartis USD 7.56B 594M 2024-12
Pfizer USD 16.09B 1.35B 2025-06
PTC Therapeutics USD 196.13M 14.36M 2025-06
Regeneron Pharmaceuticals USD 5.61B 49M 2025-06
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 8.21B 7.76B 2025-06
Sarepta Therapeutics USD 609.6M 114.93M 2025-06
Takeda JPY 679.53B 45.72B 2025-06
Teva Pharmaceutical Industries USD 3.56B 180M 2025-06
Ultragenyx Pharmaceutical USD 124.46M 25.62M 2025-06
Vertex Pharmaceuticals USD 1.89B 88.4M 2025-06


Amgen Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.